Tapewire

Nasdaq · USD

CNSP

CNS Pharmaceuticals, Inc.

Export transactions ↓
Tapewire entity
8048
SEC CIK
0001729427
Parsed reports
90

Last 12 months

Inside the activity.

2 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202620
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 15, 2021 Filed Jul 16, 2021 21:00 UTC GrantOption to purchase common stock · Derivative 32,000 Not disclosed Strike: $1.80 Not disclosed
Disclosure

SEC source: 0001683168-21-002998 · ownership.xml · derivative · entry 1

Evans Carl Anthony · CIK 0001792582 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 178,559

Underlying: Common Stock · 32,000 shares

Expires 2031-07-15

F2 · price: The stock options were issued in connection with the reporting person's Board of Director services to the Company.

F1 · derivative.exercise_date: The stock options set forth in this table vest on the earlier of the one-year anniversary of the date hereof or the date of the 2022 annual meeting, subject to the grantee's continued service to the Company on the vesting date.

Read SEC document
February 05, 2021 Filed Feb 9, 2021 22:00 UTC
Downs Christopher SChief Financial Officer
GrantOption to purchase common stock (right to buy) · Derivative 131,000 Not disclosed Strike: $3.36 Not disclosed
Disclosure

SEC source: 0001683168-21-000448 · ownership.xml · derivative · entry 1

Downs Christopher · CIK 0001705978 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 431,000

Underlying: Common Stock · 131,000 shares

Expires 2031-02-05

F2 · price: The stock options were issued in connection with the reporting person's employment with the Company.

F1 · derivative.exercise_date: The stock options set forth in this table vest in four equal annual installments beginning on the first anniversary of the Transaction Date and are subject to the grantee's continued service to the Company on each vesting date.

Read SEC document
February 05, 2021 Filed Feb 9, 2021 17:00 UTC
Climaco John MDirector · Chief Executive Officer
GrantOption to purchase common stock (right to buy) · Derivative 310,000 Not disclosed Strike: $3.36 Not disclosed
Disclosure

SEC source: 0001683168-21-000447 · ownership.xml · derivative · entry 1

Climaco John M · CIK 0001546797 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 749,500

Underlying: Common Stock · 310,000 shares

Expires 2031-02-05

F2 · price: The stock options were issued in connection with the reporting person's employment with the Company.

F1 · derivative.exercise_date: The stock options set forth in this table vest in four equal annual installments beginning on the first anniversary of the Transaction Date and are subject to the grantee's continued service to the Company on each vesting date.

Read SEC document
August 24, 2020 Filed Aug 25, 2020 23:11 UTC
Downs Christopher SChief Financial Officer
PurchaseCommon Stock 142,000 $2.04 $289,680.00
Disclosure

SEC source: 0001683168-20-002862 · ownership.xml · nonDerivative · entry 1

Downs Christopher · CIK 0001705978 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 142,000

F1 · price: This transaction was executed in multiple trades at prices ranging from $1.84 to $2.30. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
June 12, 2020 Filed Jun 16, 2020 21:23 UTC GrantOption to purchase common stock · Derivative 46,559 Not disclosed Strike: $2.47 Not disclosed
Disclosure

SEC source: 0001683168-20-001968 · ownership.xml · derivative · entry 1

Keyes Jeffry R. · CIK 0001557736 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 146,559

Underlying: Common Stock · 46,559 shares

Expires 2030-06-12

F2 · price: The stock options were issued in connection with the reporting person's Board of Director services to the Company.

F1 · derivative.exercise_date: The stock options set forth in this table vest on the earlier of the one-year anniversary of the issuance date or the date of the 2021 annual meeting, subject to the grantee's continued service to the Company on the vesting date.

Read SEC document
June 12, 2020 Filed Jun 16, 2020 21:23 UTC GrantOption to purchase common stock · Derivative 46,559 Not disclosed Strike: $2.47 Not disclosed
Disclosure

SEC source: 0001683168-20-001966 · ownership.xml · derivative · entry 1

Evans Carl Anthony · CIK 0001792582 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 146,559

Underlying: Common Stock · 46,559 shares

Expires 2030-06-12

F2 · price: The stock options were issued in connection with the reporting person's Board of Director services to the Company.

F1 · derivative.exercise_date: The stock options set forth in this table vest on the earlier of the one-year anniversary of the issuance date or the date of the 2021 annual meeting, subject to the grantee's continued service to the Company on the vesting date.

Read SEC document
June 12, 2020 Filed Jun 16, 2020 21:23 UTC GrantOption to purchase common stock · Derivative 46,559 Not disclosed Strike: $2.47 Not disclosed
Disclosure

SEC source: 0001683168-20-001967 · ownership.xml · derivative · entry 1

Gumulka Jerzy · CIK 0001793252 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 146,559

Underlying: Common Stock · 46,559 shares

Expires 2030-06-12

F2 · price: The stock options were issued in connection with the reporting person's Board of Director services to the Company.

F1 · derivative.exercise_date: The stock options set forth in this table vest on the earlier of the one-year anniversary of the issuance date or the date of the 2021 annual meeting, subject to the grantee's continued service to the Company on the vesting date.

Read SEC document
June 12, 2020 Filed Jun 16, 2020 21:22 UTC GrantOption to purchase common stock · Derivative 46,559 Not disclosed Strike: $2.47 Not disclosed
Disclosure

SEC source: 0001683168-20-001965 · ownership.xml · derivative · entry 1

Andraczke Andrzej · CIK 0001792732 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 146,559

Underlying: Common Stock · 46,559 shares

Expires 2030-06-12

F2 · price: The stock options were issued in connection with the reporting person's Board of Director services to the Company.

F1 · derivative.exercise_date: The stock options set forth in this table vest on the earlier of the one-year anniversary of the issuance date or the date of the 2021 annual meeting, subject to the grantee's continued service to the Company on the vesting date.

Read SEC document
May 05, 2020 Filed Jan 25, 2022 16:05 UTC OtherCommon Stock 1,495,867 Not disclosed Not disclosed
Disclosure

SEC source: 0001683168-22-000460 · ownership.xml · nonDerivative · entry 1

Priebe Waldemar · CIK 0001678516 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 7,533,133

F1 · price: The shares are held by a limited liability company for which the reporting person's adult child is the sole manager and adult children are sole members. Prior to May 5, 2020, the reporting person was a manager of the limited liability company. The reporting person ceased to be a manager of the limited liability company on May 5, 2020, and since such date has not had any voting or dispositive power over the shares held by the limited liability company. The reporting person has never had a pecuniary interest in the limited liability company.

F2 · ownership.nature: Consists of: (i) 7,333,133 shares of common stock held by a limited liability company; and (ii) 200,000 shares held by Houston Pharmaceuticals, Inc.

Read SEC document
November 13, 2019 Filed Nov 13, 2019 22:12 UTC
Downs Christopher SChief Financial Officer
GrantOption to purchase common stock (right to buy) · Derivative 300,000 Not disclosed Strike: $4.00 Not disclosed
Disclosure

SEC source: 0001683168-19-003571 · ownership.xml · derivative · entry 1

Downs Christopher · CIK 0001705978 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 300,000

Underlying: Common Stock · 300,000 shares

Expires 2029-11-13

F2 · price: The stock options were issued in connection with the reporting person's employment with the Company.

F1 · derivative.exercise_date: The stock options set forth in this table vest in four equal annual installments beginning on the first anniversary of the Transaction Date and are subject to the grantee's continued service to the Company on each vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.